News Article | April 24, 2017
ANN ARBOR, Mich., April 24, 2017 /PRNewswire/ -- Truven Health Analytics®, part of the IBM Watson HealthTM business, released its annual study identifying 15 Top U.S. health systems based on balanced, system-wide clinical and administrative performance. Among the key findings in...
News Article | April 25, 2017
The hospitals included on this list are renowned for excellence. They are industry leaders in innovation, quality patient care and clinical research, and have received recognition across various publications and accrediting organizations. Becker's Hospital Review has published a version of this list since 2012. The Becker's Hospital Review editorial team selected hospitals for inclusion based on analysis of several ranking and award agencies, including U.S. News and World Report's 2016-17 Honor Roll and specialty rankings, CMS star ratings, Leapfrog grades, Truven Health Analytics top hospitals, Most Wired hospitals and Magnet accreditation. The full list features individual profiles of all hospitals on the list. The full list can be read here. Note: This list is not an endorsement of included hospitals, health systems or associated healthcare providers, and organizations cannot pay for inclusion on this list. Organizations are presented in alphabetical order.
News Article | April 24, 2017
News Article | May 3, 2017
The American Association for Physician Leadership® announces the election of two new leaders of its board of directors and three accomplished physician leaders to join its board of directors. The new board leaders and members begin their tenure in May and serve four-year terms. New Board Chair: Alan P. Marco, MD, MMM, CPE, FAAPL Marco serves as president and CEO of Wright State Physicians, the faculty practice group at Wright State University Boonshoft School of Medicine in Dayton, Ohio. New Vice Chair: Daniel A. Lace, MD, CPE, FAAPL Lace serves as chief medical officer and principal of Leaders in Medicine, based in Wayne, Illinois. New Board Member: Thomas Higgins, MD, MBA, CPE, FACP, MCCM Higgins serves as chief medical officer at Baystate Franklin Medical Center in Greenfield, Massachusetts, and Baystate Noble Hospital in Westfield, Massachusetts. New Board Member: Lisa Laurent, MD, MBA, CPE Laurent serves as president-elect of the medical staff and chairman of the credentials committee at Advocate Lutheran General Hospital and President of Advanced Radiology Consultants, both in Park Ridge, Illinois. New Board Member: Byron C. Scott, MD, MBA, CPE, FACEP, FAAPL Scott serves as associate chief medical officer for Truven Health Analytics, which is part of the IBM Watson Health business unit, and on staff at Northwestern Medicine’s Immediate Care Center, both in Chicago, Illinois. “This talented group of physicians will enhance the strength of our board,” says Peter Angood, MD, FRCS(C), FACS, MCCM, president and CEO of the association. “The members continue to endorse our goal of having many skills and facets within health care reflected among our board members.” The board of directors is made up of fellows or distinguished fellows of the association or members attaining a master’s degree with an association partner university. Candidates are nominated by their peers. A slate of candidates is brought before the membership in an online election in the first quarter of the year. Honoring Fellows: Dennis K. Wentz, MD, CCHP, FAAPL, was named a distinguished fellow of the association, and David J. Shulkin, MD, ACPL, FAAPL, and Ramanathan Raju, MD, MBA, FACS, FACHE, FAAPL, were named honorary fellows. Shulkin is the U.S. Secretary of Veteran Affairs, appointed to office in February. Other board members: Laura Clapper, MD, MPPA, CPE, FAAPL; Gregory Jolissaint, MD, MS, CPE, FAAPL; and Mark Lester, MD, MBA, CPE, FAANS, FACS, FACPE; Bret Burton, MD, MBA, CPE, FAAPL; Howard Shaw, MD, MBA, CPE, FACOG, FAAPL; Albert Tzeel, MD, MHSA, CPE, FAAPL; past chair Napoleon Knight, MD, MBA, CPE, FACEP, FAAPL. Retiring from the board are William R. Casperson, MD, FACS, CPE, FAAPL; and Anthony D. Slonim, MD, DrPH, CPE, FAAPL. The American Association for Physician Leadership® is the only professional organization dedicated to providing education, career support and advocacy to support physician leaders as they create transformative solutions within the rapidly evolving field of health care. Founded in 1975 as the American College of Physician Executives (ACPE), the nonprofit association has educated thousands of physicians worldwide and has members in 46 countries at varying stages of their careers. The association is known for its award-winning magazine, the Physician Leadership Journal, its continuing medical education (CME) courses, and its Certified Physician Executive (CPE) certification program. Based in Tampa, Florida, the association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education credits, and by the Certifying Commission in Medical Management to award CPE certification. Learn more online at physicianleaders.org, via email at info(at)physicianleaders(dot)org, or call 800-562-8088.
News Article | April 21, 2017
NORC researchers reviewed available information related to FAIR Health, three other national databases and 15 state APCDs to determine the most reliable source of data when benchmarking out-of-network physician reimbursements at in-network facilities. The criteria on which NORC evaluated the databases, which were developed in consultation with Physicians for Fair Coverage, included: This analysis showed that FAIR Health met the most criteria and indicated FAIR Health is an important potential source of data. An important differentiator is that FAIR Health licenses their data for out-of-network benchmarking purposes unlike most other national data sources. This independent research showed that FAIR Health not only has an exceptionally large and geographically representative database, but also due to the ability to search data in a geographical zip code, offers deep local comparisons of physician charges. This conclusion follows, in part, from the following attributes of FAIR Health: For the purpose of identifying a standard benchmark, outlined by Physicians for Fair Coverage in the study, NORC's review found that using data from a national vendor had advantages over state APCDs. NORC found that APCD data and access processes are not uniform across states, and because of these limitations, rendering a nation-wide standard and process for analysis of claims and costs associated with the establishment and maintenance of the databases very difficult. Moreover, the recent Supreme Court decision in Gobielle v. Liberty Mutual Insurance Company means that states cannot require ERISA-regulated self-funded plans to report data, making it more difficult to apply benchmarks based on these data. "Our review found that FAIR Health offers a useful and localized data set that can be utilized to help inform policymaking with respect to how to reimburse for medical services provided by out-of-network physicians," said Jon Gabel, NORC's lead researcher. "Legislators across the country are recognizing that surprise insurance gaps are leaving patients exposed," said Michele Kimball, CEO, Physicians for Fair Coverage. "As they work to close these gaps caused by insurers narrowing physician networks, this NORC analysis demonstrates that using the FAIR Health database to better understand for out-of-network payments is the more comprehensive, transparent and inexpensive avenue for legislators compared to any other national or state database." The other three national vendors NORC reviewed are: Health Care Cost Institute, Blue Health Intelligence and Truven Health Analytics. The state based APCD's NORC examined in the report are: Arkansas, Colorado, Kansas, Maine, Maryland, Massachusetts, Minnesota, New Hampshire, Oregon, Rhode Island, Tennessee, Utah, Vermont, Virginia and Washington. NORC conducted web-based research and a grey literature review to gain insights into vendors and databases. Then, NORC conducted phone interviews with executives from each organization to gather information about the organizations, the data each they maintain, and processes for accessing those data. The authors of the NORC study will formally unveil and discuss it Friday at 12:15 PM Eastern Time at the University of Georgia Law School symposium focusing on rural healthcare. The symposium will be broadcast via live stream. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/independent-research-funded-by-physicians-for-fair-coverage-shows-that-fair-health-is-a-useful-source-of-data-for-out-of-network-physician-charge-benchmarking-300443289.html
News Article | May 1, 2017
SAN DIEGO, CA--(Marketwired - May 01, 2017) - Hubert Greenway, M.D., chairman of Mohs and dermatologic surgery at Scripps Clinic, received the Frederic E. Mohs Award from the American College of Mohs Surgery at the college's annual meeting in San Francisco on April 28. The award honors Dr. Greenway's lifetime achievements in promoting Mohs surgery for skin cancer, through teaching, clinical practice, scientific contributions, innovation, mentorship and service. Unique surgical technique The late Dr. Mohs developed the Mohs surgical technique, which involves surgically removing skin cancer layer by layer and examining the tissue microscopically until healthy, cancer-free tissue around the tumor is reached. The technique's precision, tissue-preserving capabilities and success rates of up to 99 percent make it a preferred treatment for various skin cancers. "Dr. Greenway has made enormous contributions to the field of Mohs surgery and to the many skin cancer patients he has successfully treated at Scripps," said Scripps Health President and CEO Chris Van Gorder. "We are delighted to see him receive this richly deserved recognition." Clinical and academic leadership Since joining Scripps Clinic in 1984, Dr. Greenway has performed more than 31,000 Mohs surgery cases and has trained 46 fellows, who today practice throughout the world in academic and clinical settings. His career also includes numerous teaching roles, several clinical research studies published in peer-reviewed journals, and multiple chapters contributed to medical textbooks. Trained by Dr. Frederic Mohs Dr. Greenway was fellowship-trained in Mohs skin cancer surgery by Dr. Mohs at the University of Wisconsin in Madison. He earned his medical degree from the Medical College of Georgia in Augusta and his bachelor's degree from the University of Georgia in Athens. He is board-certified by the American Board of Dermatology, American Board of Mohs Surgery and American Board of Family Practice. A resident of Rancho Santa Fe, Calif., Dr. Greenway is a past chief executive officer of Scripps Clinic and a former president of the American College of Mohs Surgery. His medical service also includes assignments with the United States Navy, Air Force and Marines. In August, Scripps announced a partnership with MD Anderson Cancer Center to create a comprehensive and clinically integrated cancer care program in San Diego. Work to establish the Scripps MD Anderson Cancer Center is now under way, and the program will be developed during the coming months. Established in 1967, the American College of Mohs Surgery promotes and advances the highest standards of patient care with respect to Mohs surgery and cutaneous oncology through fellowship training, research, education and public advocacy. ABOUT SCRIPPS HEALTH Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a nonprofit integrated health care delivery system based in San Diego, Calif. Scripps treats more than 700,000 patients annually through the dedication of 3,000 affiliated physicians and more than 15,000 employees among its five acute-care hospital campuses, hospice and home health care services, 27 outpatient centers and clinics, and hundreds of affiliated physician offices throughout the region. Recognized as a leader in disease and injury prevention, diagnosis and treatment, Scripps is also at the forefront of clinical research, genomic medicine and wireless health care. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges. Scripps has been ranked four times as one of the nation's best health care systems by Truven Health Analytics. Its hospitals are consistently ranked by U.S. News & World Report among the nation's best and Scripps is regularly recognized by Fortune, Working Mother magazine and AARP as one of the best places in the nation to work. More information can be found at www.scripps.org.
Martsolf G.R.,Truven Health Analytics
Medical Care | Year: 2014
BACKGROUND:: Inpatient quality deficits have important implications for the health and well-being of patients. They also have important financial implications for payers and hospitals by leading to longer lengths of stay and higher intensity of treatment. Many of these costly quality deficits are particularly sensitive to nursing care.OBJECTIVE:: To assess the effect of nurse staffing on quality of care and inpatient care costs.DESIGN:: Longitudinal analysis using hospital nurse staffing data and the Healthcare Cost and Utilization Project State Inpatient Databases from 2008 through 2011.SUBJECTS:: Hospital discharges from California, Nevada, and Maryland (n=18,474,860).METHODS:: A longitudinal, hospital-fixed effect model was estimated to assess the effect of nurse staffing levels and skill mix on patient care costs, length of stay, and adverse events, adjusting for patient clinical and demographic characteristics.RESULTS:: Increases in nurse staffing levels were associated with reductions in nursing-sensitive adverse events and length of stay, but did not lead to increases in patient care costs. Changing skill mix by increasing the number of registered nurses, as a proportion of licensed nursing staff, led to reductions in costs.CONCLUSIONS:: The study findings provide support for the value of inpatient nurse staffing as it contributes to improvements in inpatient care; increases in staff number and skill mix can lead to improved quality and reduced length of stay at no additional cost. © 2014 by Lippincott Williams & Wilkins.
Truven Health Analytics | Date: 2013-09-03
A system for providing medical providers with medical records accessible from a mobile terminal in one embodiment comprises reformatting the information in a medical record database to be used with large, ergonomic icons allowing easy transitions between pages of information in the medical record. Docking stations or wireless networks may enable the mobile terminal to access the medical records. Thus, the medical provider may have bedside access to the information in the medical records to make informed decisions about treatment regimens.
News Article | March 3, 2017
POLL: More People Are Taking Opioids, Even As Their Concerns Rise Prescribed narcotic painkillers continue to fuel a nationwide opioid epidemic—nearly half of fatal overdoses in the United States involve opioids prescribed by a doctor. But people don't seem to be avoiding the medications, despite the well-documented risks. In the latest NPR-Truven Health Analytics poll, over half of people surveyed, or 57 percent, said they had been prescribed a narcotic painkiller like Percocet, Vicodin or morphine at some point. That's an increase of 3 percent since we last asked the question in 2014 (54 percent), and of 7 percent since our 2011 poll (50 percent). For almost three quarters of poll participants (74 percent), the prescription was for temporary acute pain, like from a broken arm or a dental procedure. Nineteen percent said they received the drugs for chronic pain. "The drugs are like a two-edged sword," says Ron Ozminkowski, vice president of cognitive analytics in the value-based care pillar at IBM Watson Health, who works with Truven on the poll. "They're great for people who really need them for heavy duty pain, but they come with addiction risk and side effects." Indeed, the Centers for Disease Control and Prevention note that as many as 1 in 4 people who use opioid painkillers get addicted to them. But despite the drugs' reputation for addiction, less than a third of people (29 percent) said they questioned or refused their doctor's prescription for opioids. That hasn't changed much since 2014 (28 percent) or 2011 (31 percent). Dr. Leana Wen, an emergency physician and commissioner of health for the City of Baltimore, says that's the problem. She says patients should more readily voice their concerns about getting a prescription for narcotics to make sure if it really is the best option. If prescribing a narcotic painkiller is on the table, physicians should reference the opioid prescribing guidelines from the Centers for Disease Control and Prevention, Wen says. Released in March of last year, the guidelines recommend trying non-narcotic medications or treatments first; lay out recommendations for when to prescribe the drugs; how to choose the appropriate painkiller and dosage; and how to assess risks. The guidelines are intended for primary care physicians, and not for those treating patients in end-of-life care or with cancer. "Ask why," Wen says. "Often, other alternatives like not anything at all, taking an ibuprofen or Tylenol, physical therapy, or something else can be effective. Asking 'why' is something every patient and provider should do." That message may be getting through. Many more poll participants expressed uneasiness about opioid painkillers, whether they'd been prescribed the drugs or not. Almost half of people who said they hadn't used narcotic painkillers said they had concerns about them, up significantly from 30 percent in 2014 and 2011. Getting addicted to painkillers was their top concern (39 percent), followed by side effects (22 percent). Among respondents who were taking opioids, 35 percent had concerns, down 1 percent from 2014 and 2011. As with prior polls, people taking opioids were more worried about side effects (38 percent) than addiction (27 percent). We asked poll participants if they thought certain side effects were linked to taking opioids. More than three quarters thought addiction was associated with the drugs. They're right — nearly 2 million Americans abused or were dependent on opioids in 2014, and it's estimated that over 1,000 people a day wind up in emergency rooms across the nation for misuse of prescription opioids. Two-thirds said they thought opioids were linked with constipation. And that's true; 41 percent of people taking opioids experienced constipation in one study, and another lists the side effect as "expected" with the use of opioids. There are even drugs being marketed specifically to combat constipation caused by prescribed narcotic painkillers. Aside from worrying about addiction or side effects, respondents also worried about narcotics' long-term health impact (14 percent) and their association with drug abuse (13 percent). "Doctors have to think twice about how they use the tools in their pain killing tool kit," Ozminkowski says. Wen agrees. "We must all take steps to fix this overprescribing. Heed the guidelines from the Centers for Disease Control and Prevention that say go low and go slow — start with the least harmful and least addictive and work your way up," she says. "We need to treat pain, but appropriately." The poll gathered responses from 3,000 participants questioned over the phone and online from November 1 to 15, 2016. The margin for error is plus or minus 1.8 percentage points. You can find the complete set of questions and results here. Past NPR-Truven Health polls can be found here.
News Article | February 15, 2017
Artificial intelligence (AI) can be understood as a science, engineering and deployment of machines, which perform tasks with intelligence as similar to humans. Since its inception 60 years ago, AI has observed significant growth in recent years. Initially, AI was considered as topic for academicians, though in recent years with development of various technologies, AI has turned into reality and is influencing many lives and businesses. Additionally, evolution of various other supplementary technologies such as cloud computing, machine learning and cognitive computing are collectively paving the growth of the market for AI. According to Mr. Sachin Garg - Associate Director at MarketsandMarkets who tracks the global semiconductor market, the global artificial intelligence chipset market is expected to be worth USD 16.06 Billion by 2022, growing at a CAGR of 62.9% between 2016 and 2022. Many IT giants and start-ups are investing heavily in development of AI software solutions and hardware products. Some the prominent players in AI Market in the recent times are Intel Corporation (U.S.), Google Inc. (U.S.), Microsoft Corporation (U.S.), Amazon.com, Inc. (U.S.), Baidu, Inc. (China), and NVIDIA Corporation (U.S.). Early buyers will receive 10% customization on this report. Significant development in various technologies such as deep learning and natural language processing technologies has emanated the growth of AI market Computer vision technology has become a part of high definition video games, while deep learning; which is a subset of machine learning is now implemented in speech recognition, drug discovery, health monitoring and various others applications. Robotics has evolved as one of the most promising AI technology in recent times. With wide range of applications, AI enabled robots are nowadays applied in welding, cutting, color coating and polishing purposes in automotive industry; carrying out several clinical tests and performing surgeries in healthcare industry. Furthermore, robotics and AI are likely to benefit the industries which are lacking the skilled and young workforce such as agriculture, factories, food processing and fulfillment centers. As per Mr. Garg, AI is likely to gain traction with amalgamation of various technologies such as deep learning, robotics, digital personal assistance, querying, natural language processing, and context-aware processing to develop an AI-featured product. In near future, AI is expected to make a crucial impact in multiple end-use applications such as driverless cars, healthcare diagnostics, and physical assistance in elder care Transportation & Automotive, Media & Advertising, Retail were the key contributor to the AI market in 2015 AI is likely to disrupt every business segment across the world. The end-use industries of AI featured in this AI market study includes, agriculture, BFSI, manufacturing, healthcare, oil & gas, media & advertising, transportation and automotive, retail, among others. Among these verticals, transportation and automotive sector was the largest contributor to the AI market in 2015. This was resultant of significant investment made by federal governments and venture capitalists in development of connected and autonomous vehicles. These funding consequently resulted in some of the tangible recent development in autonomous projects. For instance, in October 2016, Otto (U.S.) (now acquired by Uber Technologies, Inc. (U.S.)) shipped its first consignment from Denver, Colorado, U.S. to Denver Springs, U.S. using driverless truck. The autonomous driving was carried for 120 mile journey. However, healthcare industry is estimated to exhibit highest growth in near term. The growing penetration of AI in health care assistance and medical management are the two key factors driving the market for the healthcare industry. Moreover, AI technologies are also used in the healthcare industry for decision-making processes, extracting information from the data collected from patients, and processing it further for testing and simulation of new treatments, scenarios, and devices. The increasing large and complex datasets even called as big data, and the adoption of AI-enabled products and services to improve consumer-centric services are the two major growth drivers of the AI market. However, the scarcity of low cost and energy efficient hardware, and the lack of skilled workforce for development of AI algorithms and tools is curbing the growth of the AI market. In essence, AI offers significant growth opportunities to all the stakeholders involved in its ecosystem. Development of human-aware AI systems and widening scope of AI technologies in niche markets are prominent market opportunities existing today. In addition to this, deploying AI at the edge of the network is likely to become a massive industry trend in coming years. From new product launches to mergers & acquisitions, AI industry has witnessed some tremendous and crucial developments in recent years. Many companies are relying on their in-house developments, while some are growing with inorganic growth practices. Google, one of the frontrunners in AI had launched industry's first AI-enabled smartphone "Pixel" in October 2016, which signifies that AI is now turning into a reality. On the other hand, IBM acquired Truven Health Analytics (U.S.) in April 2016, with this IBM intent to derive insights from Truven's health data using Watson Health's cognitive capabilities. On similar lines, in January 2016, IBM acquired The Weather Company, based in Atlanta, Georgia (U.S.) to introduce a new platform for IBM Watson Internet of Things. Alongside this, leading graphics processing unit (GPU) providers, NVIDIA Corporation launched the industry's first deep learning system, "NVIDIA DGX- 1", in April 2016. This tool is a completely integrated system with deep learning hardware and software, and development tool kit. Thus, AI technologies are the future for many industries which are striving for efficient, low-cost operations and high profitability in their markets Neuromorphic Computing Market by Offering (Hardware, Software), Application (Image Recognition, Signal Recognition, Data Mining), Industry (Aerospace & Defense, IT & Telecom, Automotive, Medical & Industrial) and Geography - Global Forecast to 2022 http://www.marketsandmarkets.com/Market-Reports/neuromorphic-chip-market-227703024.html Deep Learning Market by Application (Image Recognition, Signal Recognition, Data Mining), Offering (Hardware (Von Neumann and Neuromorphic Chip), and Software), End-User Industry, and Geography - Global Forecasts to 2022 MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical info graphics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.